1. Moet GJ, Jones RN, Biedenbach DJ, Stilwell MG, Fritsche TR. Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998–2004). Diagn Microbiol Infect Dis. 2007; 57:7–13.
Article
2. Edelsberg J, Taneja C, Zervos M, Haque N, Moore C, Reyes K, et al. Trends in US hospital admissions for skin and soft tissue infections. Emerg Infect Dis. 2009; 15:1516–1518.
Article
3. Pallin DJ, Egan DJ, Pelletier AJ, Espinola JA, Hooper DC, Camargo CA Jr. Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant
Staphylococcus aureus
. Ann Emerg Med. 2008; 51:291–298.
Article
4. Chuang YY, Huang YC. Molecular epidemiology of community-associated meticillin-resistant
Staphylococcus aureus in Asia. Lancet Infect Dis. 2013; 13:698–708.
Article
5. Ma SH, Lee YS, Lee SH, Kim HK, Jin JS, Shin EK, et al. Meticillin-resistant
Staphylococcus aureus clones with distinct clinical and microbiological features in a Korean community. J Med Microbiol. 2007; 56:866–868.
Article
6. Choe YJ, Lee SY, Sung JY, Yang MA, Lee JH, Oh CE, et al. A review of
Staphylococcus aureus infections in children with an emphasis on community-associated methicillin-resistant
S. aureus infections. Korean J Pediatr Infect Dis. 2009; 16:150–161.
Article
7. Velasco D, del Mar Tomas M, Cartelle M, Beceiro A, Perez A, Molina F, et al. Evaluation of different methods for detecting methicillin (oxacillin) resistance in
Staphylococcus aureus
. J Antimicrob Chemother. 2005; 55:379–382.
Article
8. Klein E, Smith DL, Laxminarayan R. Hospitalizations and deaths caused by methicillin-resistant
Staphylococcus aureus, United States, 1999–2005. Emerg Infect Dis. 2007; 13:1840–1846.
Article
9. Landrum ML, Neumann C, Cook C, Chukwuma U, Ellis MW, Hospenthal DR, et al. Epidemiology of Staphylococcus aureus blood and skin and soft tissue infections in the US military health system, 2005–2010. JAMA. 2012; 308:50–59.
10. Sutter DE, Milburn E, Chukwuma U, Dzialowy N, Maranich AM, Hospenthal DR. Changing susceptibility of
Staphylococcus aureus in a US pediatric population. Pediatrics. 2016; 137:e20153099.
Article
11. Johnson AP, Davies J, Guy R, Abernethy J, Sheridan E, Pearson A, et al. Mandatory surveillance of methicillin-resistant
Staphylococcus aureus (MRSA) bacteraemia in England: the first 10 years. J Antimicrob Chemother. 2012; 67:802–809.
Article
12. European Centre for Disease Prevention and Control (ECDC). Antimicrobial resistance (EARS-Net). ECDC. Annual epidemiological report for 2014. Stockholm: ECDC;2018. p. 1–14.
13. Moon HW, Kim HJ, Hur M, Yun YM. Antimicrobial susceptibility profiles of
Staphylococcus aureus isolates classified according to their origin in a tertiary hospital in Korea. Am J Infect Control. 2014; 42:1340–1342.
Article
14. Kim ES, Kim HB, Kim G, Kim KH, Park KH, Lee S, et al. Clinical and epidemiological factors associated with methicillin resistance in community-onset invasive Staphylococcus aureus infections: prospective multicenter cross-sectional study in Korea. PLoS One. 2014; 9:e114127.
15. Baek YS, Jeon J, Ahn JW, Song HJ. Antimicrobial resistance of Staphylococcus aureus isolated from skin infections and its implications in various clinical conditions in Korea. Int J Dermatol. 2016; 55:e191–e197.
16. Lim S, Ha SG, Tchah H, Jeon IS, Ryoo E, Son DW, et al. Epidemiology of
Staphylococcus aureus bacteremia in children at a single center from 2002 to 2016. Pediatr Infect Vaccine. 2019; 26:11–21.
Article
17. Shin SM, Shin JY, Kim MH, Lee SH, Choi S, Park BJ. Prevalence of antibiotic use for pediatric acute upper respiratory tract infections in Korea. J Korean Med Sci. 2015; 30:617–624.
Article
18. Park JM, Jo JH, Jin H, Ko HC, Kim MB, Kim JM, et al. Change in antimicrobial susceptibility of skin-colonizing
Staphylococcus aureus in Korean patients with atopic dermatitis during ten-year period. Ann Dermatol. 2016; 28:470–478.
Article
19. Hwang Y, Kang JS, Kim BK, Kim SW. Colonization of
Staphylococcus aureus and sensitivity to antibiotics in children with atopic dermatitis. Allergy Asthma Respir Dis. 2017; 5:21–26.
Article
20. Kaplan SL. Treatment of community-associated methicillin-resistant
Staphylococcus aureus infections. Pediatr Infect Dis J. 2005; 24:457–458.
Article
21. Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clin Infect Dis. 2014; 59:147–159.
Article
22. Herigon JC, Hersh AL, Gerber JS, Zaoutis TE, Newland JG. Antibiotic management of Staphylococcus aureus infections in US children's hospitals, 1999–2008. Pediatrics. 2010; 125:e1294–e1300.
23. Khamash DF, Voskertchian A, Tamma PD, Akinboyo IC, Carroll KC, Milstone AM. Increasing clindamycin and trimethoprim-sulfamethoxazole resistance in pediatric
Staphylococcus aureus infections. J Pediatric Infect Dis Soc. 2019; 8:351–353.
Article
24. Song YK, Han N, Kim MG, Chang HJ, Sohn HS, Ji E, et al. A national pharmacoepidemiological study of antibiotic use in Korean paediatric outpatients. Arch Dis Child. 2017; 102:660–666.
Article
25. Levi N, Bastuji-Garin S, Mockenhaupt M, Roujeau JC, Flahault A, Kelly JP, et al. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis. Pediatrics. 2009; 123:e297–e304.
Article
26. Williams DJ, Cooper WO, Kaltenbach LA, Dudley JA, Kirschke DL, Jones TF, et al. Comparative effectiveness of antibiotic treatment strategies for pediatric skin and soft-tissue infections. Pediatrics. 2011; 128:e479–e487.
Article
27. Miller LG, Daum RS, Creech CB, Young D, Downing MD, Eells SJ, et al. Clindamycin versus trimethoprim-sulfamethoxazole for uncomplicated skin infections. N Engl J Med. 2015; 372:1093–1103.
Article
28. Grossman ER, Walchek A, Freedman H, Flanagan C. Tetracyclines and permanent teeth: the relation between dose and tooth color. Pediatrics. 1971; 47:567–570.
Article
29. Friedman ND, Temkin E, Carmeli Y. The negative impact of antibiotic resistance. Clin Microbiol Infect. 2016; 22:416–422.
Article